These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32879337)

  • 21. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention.
    Goncalvez AP; Engle RE; St Claire M; Purcell RH; Lai CJ
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9422-7. PubMed ID: 17517625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed antibody dependent enhancement of low passage dengue virus 4 isolates.
    Wikan N; Libsittikul S; Yoksan S; Auewarakul P; Smith DR
    BMC Res Notes; 2015 Sep; 8():399. PubMed ID: 26328895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication.
    Suzuki Y; Chin WX; Han Q; Ichiyama K; Lee CH; Eyo ZW; Ebina H; Takahashi H; Takahashi C; Tan BH; Hishiki T; Ohba K; Matsuyama T; Koyanagi Y; Tan YJ; Sawasaki T; Chu JJ; Vasudevan SG; Sano K; Yamamoto N
    PLoS Pathog; 2016 Jan; 12(1):e1005357. PubMed ID: 26735137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement.
    Londono-Renteria B; Troupin A; Cardenas JC; Hall A; Perez OG; Cardenas L; Hartstone-Rose A; Halstead SB; Colpitts TM
    J Gen Virol; 2017 Jul; 98(7):1702-1712. PubMed ID: 28691657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel dengue virus inhibitor 4-HPR activates ATF4 independent of protein kinase R-like Endoplasmic Reticulum Kinase and elevates levels of eIF2α phosphorylation in virus infected cells.
    Fraser JE; Wang C; Chan KW; Vasudevan SG; Jans DA
    Antiviral Res; 2016 Jun; 130():1-6. PubMed ID: 26965420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection.
    Wang Y; Si LL; Guo XL; Cui GH; Fang DY; Zhou JM; Yan HJ; Jiang LF
    Virus Res; 2017 Feb; 229():57-64. PubMed ID: 27939945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct Infection of B Cells by Dengue Virus Modulates B Cell Responses in a Cambodian Pediatric Cohort.
    Upasani V; Vo HTM; Auerswald H; Laurent D; Heng S; Duong V; Rodenhuis-Zybert IA; Dussart P; Cantaert T
    Front Immunol; 2020; 11():594813. PubMed ID: 33643283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.
    Shukla R; Beesetti H; Brown JA; Ahuja R; Ramasamy V; Shanmugam RK; Poddar A; Batra G; Krammer F; Lim JK; Kale S; Lal AA; Swaminathan S; Khanna N
    EBioMedicine; 2020 Oct; 60():102991. PubMed ID: 32949997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection.
    Choy MM; Zhang SL; Costa VV; Tan HC; Horrevorts S; Ooi EE
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004058. PubMed ID: 26565697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of antibodies in controlling dengue virus infection.
    van der Schaar HM; Wilschut JC; Smit JM
    Immunobiology; 2009; 214(7):613-29. PubMed ID: 19261353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
    Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
    Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
    Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
    BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of dengue virus entry into myeloid cells by endocytic inhibitors in the presence or absence of antibodies.
    Carro AC; Piccini LE; Damonte EB
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006685. PubMed ID: 30092029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
    Uno N; Ross TM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sweeping analysis of transcript profile in dengue virus serotype 3 infection and antibody-dependent enhancement of infection.
    Long M; Pan Y; Chen J; Jia F; Wang H; Li D; Feng K; Yan L; Wang X; Ning X; Qiu L; Zhang J; Sun Q
    Virulence; 2021 Dec; 12(1):2764-2776. PubMed ID: 34699307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A lethal model of disseminated dengue virus type 1 infection in AG129 mice.
    Milligan GN; Sarathy VV; White MM; Greenberg MB; Campbell GA; Pyles RB; Barrett ADT; Bourne N
    J Gen Virol; 2017 Oct; 98(10):2507-2519. PubMed ID: 28949904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloroquine interferes with dengue-2 virus replication in U937 cells.
    Farias KJ; Machado PR; de Almeida Junior RF; de Aquino AA; da Fonseca BA
    Microbiol Immunol; 2014 Jun; 58(6):318-26. PubMed ID: 24773578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dengue virus isolation relying on antibody-dependent enhancement mechanism using FcγR-expressing BHK cells and a monoclonal antibody with infection-enhancing capacity.
    Moi ML; Lim CK; Tajima S; Kotaki A; Saijo M; Takasaki T; Kurane I
    J Clin Virol; 2011 Nov; 52(3):225-30. PubMed ID: 21824813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
    Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
    J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.